Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Exploring the interplay between circadian rhythms and obesity: A Boolean network approach to understanding metabolic dysregulation

Abstract

This study investigates the interaction between circadian rhythms and lipid metabolism disruptions in the context of obesity. Obesity is known to interfere with daily rhythmicity, a crucial process for maintaining brain homeostasis. To better understand this relationship, we analyzed transcriptional data from mice fed with normal or high-fat diet, focusing on the mechanisms linking genes involved with those regulating circadian rhythms. We performed biological enrichment analysis and Boolean network modeling to identify direct interactions between these genes. The resulting mathematical model provided a comprehensive system of gene interactions, primarily highlighting lipid metabolism. Our findings revealed key insights into the effects of obesity on circadian rhythm genes, particularly the under-expression of core genes such as Bmal1 and Clock. Crucially, we identified a reciprocal interaction between obesity and circadian genes, where disruptions on one exacerbated the dysfunction in the other. This mechanism suggests that the disruption of circadian rhythms plays a pivotal role in worsening the metabolic disturbances associated with obesity, providing new perspectives for targeting circadian pathways in obesity-related metabolic disorders.

1. Introduction

Obesity is a modern disease primarily associated with lifestyle factors. Sedentary work activities, combined with diets rich in ultra-processed foods that are often consumed in larger quantities due to their competitive cost and palatability, have contributed to metabolic balances, leading to excess weight accumulation. This surplus body mass, which is disproportionately high relative to an individual’s weight, is reflected in components of the human body that have increased in size to maintain functionality [1].

Obesity typically leads to low-grade chronic inflammation in the body, which can contribute to the development of various comorbidities. This type of inflammation is characterized by the secretion of proinflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which have systemic effects throughout the body [2]. One of the major consequences of this inflammation is the emergence of metabolic disorders, particularly metabolic syndrome [3,4]. This condition is diagnosed when at least three of the following markers are present: abdominal obesity, high blood pressure, elevated fasting blood glucose, high triglycerides, and low HDL cholesterol [5]. Metabolic syndrome is a key indicator of the increased risk for serious chronic diseases, including those related to blood sugar dysregulation and cardiovascular health [6]. These include type 2 diabetes and insulin resistance, as well as atherosclerosis. At the brain level, this persistent inflammation activates the brain’s immune system, particularly glial cells, which produce proinflammatory cytokines such as TNF- α, IL-1β, and IL-6 [79]. This chronic inflammation can accelerate brain aging by up to 10 years compared to healthy individuals [10], which can lead to critical structural changes such as reduced cortical thickness [1115]. These changes in the cortex can result in cognitive and functional impairments, including deficits in sensory perception, motor control, memory, language, communication, and emotional regulation [16].

Circadian rhythms, which regulate metabolic, physiological and behavioral coordination activities in 24-hour cycles, have a bidirectional relationship with obesity [17,18]. Obesity can disrupt these rhythms, for instance, by altering hormone production necessary for food metabolism, which may lead to insulin resistance, or by fragmenting and reducing sleep quality, impairing the coordination of energy expenditure with appetite [19]. Additionally, eating at irregular times promotes a metabolic state oriented toward caloric storage, contributing to weight gain and, ultimately, obesity [20]. This complex interplay between circadian rhythms further worsens the metabolic imbalance, as disrupted circadian rhythms become an intrinsic factor that perpetuates obesity [21]. Moreover, obesity can be influenced by external factors that disrupt circadian rhythms, such as eating late at night, exposure to artificial light, night-shift work, or even epigenetic modifications that transmit these altered rhythms [22,23].

Despite substantial progress in characterizing obesity’s pathophysiology, how it perturbs the body’s internal clock remains poorly understood [24]. To address this gap, we employ Boolean network modeling to capture- and predict- the dynamic interactions between circadian regulators and metabolic genes under both normal and high-fat diet conditions. In a Boolean framework, each gene or protein is represented as either “on” or “off”, and its state at each time step is determined by simple logical rules that helps identify conditions under which different evolutionary paths may emerge [25]. This abstraction helps us to simulate complex system behavior and identify critical points at which a high-fat diet can drive the network toward dysregulated metabolic states. Furthermore, we focus our analysis on the cerebral cortex, given evidence that obesity disrupts cortical metabolism and redox balance, with downstream effects on neurobehavioral function and glial-neuronal signalling [2635]. Although Boolean networks have proven useful in isolated studies of metabolic regulation, no prior work has integrated these approaches to map how obesity reshapes circadian-metabolic crosstalk. By constructing and simulating a Boolean model of cortex-derived transcriptomic data, we aim to reveal the system-level mechanisms by which obesity disturbs both clock genes and lipid metabolism pathways, thereby uncovering potential intervention points for restoring metabolic homeostasis.

2. Materials and methods

2.1. Murine brain datasets

We utilized a publicly available transcriptome dataset from the National Center for Biotechnology Information (2024) with accession number GSE179711. This dataset was previously analyzed to investigate the roles of non-coding RNAs in regulating cell proliferation and differentiation, neurotransmission, and neuronal excitability in the context of obesity [36]. The dataset captures genetic alterations in four male mice exposed to a high-fat diet (HFD) for 8 weeks, compared to four control mice on a normal diet (ND). Transcriptomes were collected from the brain cortex of 16-week-old mice, allowing for a direct comparison of diet-induced genetic changes.

2.2. Data preparation

Transcriptomes were assembled using the align function from the DESeq2 package [37] in the R programming language [38]. To ensure comparability, transcriptomes were normalized to account for variations due to sequencing depth, batch effects, and differences in cellular compositions [39]. This essential step allowed us for reliable comparisons across samples under similar conditions, as well as between groups exposed to different conditions. Next, differentially expressed genes (DEGs) were then identified using the limma package [40], with a significant threshold set at a p-value of 0.05. These DEGs were visualized using heatmaps, generated by the hmReady function from the ggdendroplot package [41], and volcano plots created with the EnhancedVolcano function from the EnhancedVolcano package [42].

2.2.1. Enrichment analysis.

A DAVID-based enrichment analysis [43] was conducted separately for up- and down-regulated genes, focusing on gene ontology (GO) terms: biological processes (BP), cellular components (CC), and molecular functions (MF). From the top functional annotations, we identified DEGs that were common to BP, CC, and MF categories, indicating potential functional similarities [44]. To further explore gene interactions, we analyzed these up- and down-regulated DEGs through interaction networks (PPIs) to identify clusters with more cohesive structures using the Metascape tool [45]. Metascape applies the molecular complex detection (MCODE) algorithm to pinpoint densely connected within PPIs, with region representing a functional cluster. PPIs were sourced from multiple databases: STRING, which compiles known and predicted interactions and scores them to form reliable networks [46]; BioGrid, which emphasizes biological interactions like PPIs and genetic links [47]; and OmniPath, which includes diverse interactions such as PPIs and miRNA-mRNA [48]. These networks enabled comprehensive comparative and pathways enrichment analyses.

2.2.2. Boolean networks.

The initial analysis generated undirected gene networks, meaning relationships between gene pairs were ambiguous, and causality – if present- was undefined. To address this limitation, we applied the GENIE3 algorithm [49] specifically to a network of genes associated with circadian rhythms. GENIE3 enables the construction of Boolean networks, where nodes are governed by Boolean functions that establish directed, causal relationships among genes. Since this type of network represents genes as either “on” (active) or “off” (inactive) at any given time, the Boolean functions define simple logical rules that indicate states of the genes with which they interact. This structure allowed us to simulate the network’s evolution, predicting the activation and inactivation of nodes based on initial conditions [50]. While Boolean networks provide a simplified view by treating nodes as either fully activated or inactivated, real biological interactions often involve partial activation states. More complex models, such as probabilistic networks or those based on differential equations [51,52], may capture this nuance more effectively. However, Boolean networks offer an interpretable approximation of potential system states, making them valuable for preliminary insights. The GENIE3 algorithm employs random forests [53] to simulate gene knockouts, estimating the strengths of previously undirected relationships. By setting appropriate thresholds on these estimates, the algorithm determines directed connections between genes. Since its development, GENIE3 has been widely applied to gene network inference [5456]. Finally, to understand the genetic impacts of recurrent high-fat food consumption`, we simulated the resulting Boolean network using the getAttractors function from the BoolNet package [57]. We implemented a synchronous network model, allowing multiple nodes to change states simultaneously at each step, accounting for all possible combinations of Boolean values that nodes may assume [58]. This approach facilitated the identification of stable network states, providing insights into how circadian rhythm genes respond to high-fat diets.

3. Results

The transcriptome data were processed to construct a Boolean network. S1 Fig illustrates key elements of the normalization process and some of its outcomes. In S1A Fig, the normalization effect is displayed, demonstrating comparable read counts across samples, particularly in median Q2 and upper quartile (Q3) statistics. S1B Fig presents the relationship between the observed means and standard deviations of analyzed genes. By fitting nonparametric models to describe the median trend within this scatter plot, we can assess the statistical significance of the analyzed genes.

Following the identification of differentially expressed genes (DEGs), Fig 1A highlights the 20 most statistically significant genes, categorized by their up- and down-regulated states in response to the dietary shift between normal diet (ND) and high-fat diet (HFD). This heatmap shows gene expression patterns for ND samples (left) and HFD samples (right). Although expression levels vary within these groups, overall trends emerge. For example, Gm14295 exhibits reduced expression in response to HFD, while GM2164 shows increased expression. Fig 1B displays a scatter plot of the DEGs, with the log transformations of fold change and p-value. Only genes with p-values less than 0.05 were included. Vertical reference lines are shown at log fold change of −1.5 and 1.5. In this plot, genes marked in red are considered significant, meeting the criteria of a p-value below 0.05 and a log fold change outside ±1.5. Genes with a negative log fold change are classified as down-regulated, while those with a positive log fold change are classified as up-regulated.

thumbnail
Fig 1. Features of detected DEGs.

(A) Variation in gene expression levels between the samples subjected to normal diet (ND) or high-fat diet (HFD). (B) Distribution of genes based on log fold change and log p-value.

https://doi.org/10.1371/journal.pone.0331218.g001

3.1. Gene enrichment analysis

The enrichment analysis identified the ten most significant functional annotations within the gene ontology categories BP, CC and MF. These are presented in Fig 2 for up-regulated DEGs and Fig 3 for down-regulated DEGs. Notably, for up-regulated DEGFs, the most significant functional annotations are nervous system development in BP and glutamatergic synapse in CC. These are distinguished by their markedly low p-values compared to other GO annotations within the same type of category, indicating strong enrichment. Interestingly, such distinctive functional annotations are absent when analyzing MF for up-regulated DEGs, as well as PB, CC and MF for down-regulated DEGs, suggesting unique functional shifts associated primarily with up-regulated DEGs in response to dietary change.

thumbnail
Fig 2. Top 10 significant functional annotations of up-regulated DEGs.

(A) Biological processes, (B) cellular components, and (C) molecular functions, ranked by adjusted p-values. Functional annotations are ordered by decreasing significance, with color indicating significance according to the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.

https://doi.org/10.1371/journal.pone.0331218.g002

thumbnail
Fig 3. Top 10 significant functional annotations of down-regulated DEGs.

(A) Biological processes, (B) cellular components, and (C) molecular functions, ranked by adjusted p-values. Functional annotations are ordered by decreasing significance, with color indicating significance level based on the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.

https://doi.org/10.1371/journal.pone.0331218.g003

Further genes were incorporated into the analysis using the Metascape tool, which generated a network of functional annotations related to circadian rhythms, shown in Fig 4 with up-regulated DEGs included. Detailed descriptions and types of nodes within this network are detailed in Table 1. No relevant clusters were identified among the down-regulated DEGs in terms of circadian rhythms, except for the functional annotation WP544, which is associated with circadian rhythms by physical exercise. This network includes annotations not only from BP, CC and MF, but also pathways such as mmu04710 and mmu04935. Each node represents a functional annotation, with node size indicating the number of genes within that annotation. Notably, GO:0048511 contains the highest number of genes among all annotations, followed closely by GO:0007626. The former is related to rhythmic behavior, and the latter to rhythmic process. Edges, which represent interactions between genes in different functional annotations, are weighted according to the scores by Metascape, and are visually reflected by edge thickness – the thicker the edge, the stronger the relationship. For instance, the connection between GO:0007622 and GO:0048512 is the strongest on this network. It is important to note that mmu04935 and GO:0007626 are not directly related to circadian rhythms but were included because they bridge the network shown in Fig 4 with other networks.

thumbnail
Table 1. Description of functional annotations related to circadian rhythms when considering up-regulated DEGs.

https://doi.org/10.1371/journal.pone.0331218.t001

thumbnail
Fig 4. Network of functional annotations related to circadian rhythms for upregulated DEGs.

Nodes represent functional annotations, with node size indicating the number of genes within each Edges represent relationships between nodes, with edge thickness reflecting the strength of the association.

https://doi.org/10.1371/journal.pone.0331218.g004

3.2. Building a Boolean network

The network shown in Fig 4 combined with genes present in WP544 and mmu04710 resulted in a set of 87 genes. Using the GENIE3 algorithm, we derived a direct network under ND conditions (Fig 5), which comprises 23 genes. In this network, node sizes represent the log average of normalized transcriptome counts under ND conditions, while edge weights – calculated through the GENIE3 algorithm – and graphically represented by the thickness of the edge indicate the strength of regulatory interactions. This Boolean network model represents complex biological interactions as events ‘on/off’ for gene activity, allowing us to simulate how HFD disrupts metabolic pathways. This network integrates various pathways that interact to regulate key biological processes. One prominent is circadian regulation, primarily driven by genes such as Bmal1, Clock and Npas2, which orchestrate metabolic processes in 24-hour cycles to maintain energy homeostasis [59,60]. Within this network, energy metabolism is a key pathway led by Ppargc1a, a gene crucial for mitochondrial biogenesis, oxidative metabolism, energy expenditure and adaptation to conditions like physical exercise, fasting or high-fat diets [61]. Another major pathway is lipid metabolism, represented by Fads1, which plays a role in the biosynthesis of polyunsaturated fatty acids, thereby affecting cell membrane fluidity and influencing signaling in metabolism and inflammation pathways [62,63].

thumbnail
Fig 5. Boolean network of circadian rhythms and their interplay with metabolism-related genes under normal diet conditions.

Nodes represent individual genes, with node size corresponding to the log-average of normalized transcriptome counts for each gene. Arrows indicate regulatory interactions, with their thickness representing the strength of influence from one gene to another.

https://doi.org/10.1371/journal.pone.0331218.g005

In addition to these metabolic pathways, the network includes genes involved in signal transduction such as Adcy1 and Adcy8, which support cellular communication and responses to external factors like hormones, nutrients, and environmental changes [64]. It also features genes central to transcriptional regulation, including Ep300 and Ncoa2, which adjust gene expression in response to internal and environmental changes [65,66]. Finally, genes such as Pten are involved in cell growth and survival, as they regulate the PI3K/Akt signaling pathway to maintain cellular homeostasis [67].

Table 2 presents key properties of the resulting network, calculated using functions from the igraph package [68]. The “hub” metric reflects a node’s influence within the network, measured by its degree – i.e., the number of connections a node has. Accordingly, the genes Npas2, Per1 and Pten appear to exert strong influence over other genes in the network. Edge density indicates the proportion of existing edges compared to the maximum possible number of edges in the network. Its observed value is low (0.026), indicating that the network is sparse, as expected in biological systems where not all genes interact directly. Closeness measures how close a node is to all other nodes, capturing how information can travel from this node across the network. Its moderate value (0.301) suggests that the hubs can effectively influence the broader network. Betweenness quantifies the number of shortest paths that go through a node, highlighting nodes that serve as key connectors. Its high value (0.826) indicates that the hubs may function as critical connectors or bottlenecks for information flow within the network. Lastly, entropy evaluates the distribution of degrees in the network, where a value greater than 1 suggests a high level of disorder, indicating that some genes are significantly more influential than others. This parameter reflects that the analyzed biological regulatory network is organized yet complex.

thumbnail
Table 2. Network properties of the Boolean network achieved.

https://doi.org/10.1371/journal.pone.0331218.t002

3.3. Simulation of the Boolean network

The Boolean network constructed in the previous subsection was simulated to explore its potential evolutionary states. This evolution involves generating random Boolean networks, where the nodes switch between active and inactive states. Each time a node switches its Boolean value, the network state changes, and the system evolves towards attractors – stable states that are not expected to change over time. The simulated Boolean network will eventually converge to one or more attractors, each with a certain probability of being reached. This process allowed us to track the convergence of a set of interacting genes under complex regulatory schemes [69].

Fig 6A displays the attractors achieved by the developed Boolean network under ND conditions. This figure reveals that the network can converge to 40 distinct attractors, depending on the initial Boolean values of the genes. Notably, the last four attractors demonstrate two possible evolutionary paths, leading to Hopf bifurcations. These bifurcations result in oscillatory behaviors, where the network alternates between at least two states [70]. In our cases, these cycles involve two distinct states.

thumbnail
Fig 6. Simulation of the Boolean network on circadian rhythms under (A) normal diet and (B) high fat diet conditions.

Genes are shown on the vertical axis, with their states of evolution on the horizontal axis. The final states represent the attractors reached.

https://doi.org/10.1371/journal.pone.0331218.g006

As an example, the attractor 40 whose limit state oscillates between two different states, forms an attractor with two states. In these states, all genes maintain the same Boolean values except for Dbp, Fbxw11, Nrg1, and Prg. S2 Fig illustrates the behavior of these exceptions. The figure shows iterations of all these genes together, regardless of their initial Boolean values. For instance, these genes are initially set to Active, Inactive, Active, and Active, respectively. After one iteration, the network reaches the expected states. It is noteworthy that each expected state follows directly from the previous one, without the need for further iterations. This oscillation between states generates an attractor that is governed by a Hopf bifurcation.

Next, we perturbed the developed Boolean network to reflect HFD-related conditions. For this, we consider the up-regulated and down-regulated DEGs. As shown in Fig 6A, all genes except Per1 are either up- or down-regulated. For the up-regulated genes, we set their initial condition to 1 to simulate over-expression, while for down-regulated genes, we set their initial condition to 0 to simulate knockout. However, some genes do not need to be pre-set due to the network’s intrinsic dynamics. In fact, the network’s structure and behavior allow certain expected results to emerge naturally, without requiring prior adjustment. After conducting preliminary simulations, it was determined that only the following genes needed to be fixed: Tef, Adcy8, Atp1a3, Prkn, Nr1d2, Fbxw11, Nrg1, Pgr, Sumo1, Bmal1, Pten, Npas2, Cul1 and Clock. Fig 6B shows the evolution and convergence of the perturbed network. This time, the network converged to a single attractor, achieved through a unique state. In this attractor, Per1 is downregulated. This result suggests a possible scenario for how part of the circadian rhythm genetic system may behave under a HFD, once the system stabilizes into an obesity-related gene activity pattern. Such a dynamic model could provide valuable insights for future research and potential therapeutic strategies.

4. Discussion

In this study, we constructed a biological representation of circadian rhythms using Boolean networks, offering a novel integrative approach to understanding their complex biological functions. Through this mathematical modelling framework, we were able to elucidate key interactions between circadian rhythms and various metabolic processes, specifically in the context of obesity. Importantly, the model highlights the bidirectional interaction between circadian rhythms and obesity, revealing how this metabolic dysfunction can perpetuate a cycle of regulatory imbalances.

Lipid metabolism is a crucial area of interest when addressing the implications of obesity. Notably, the Boolean network developed in this study highlights genes directly involved in lipid metabolism, revealing a strong connection between circadian rhythms and lipid homeostasis. For instance, Ppargc1a plays a key role in pathways related to lipid metabolism, including fatty acid oxidation and mitochondrial biogenesis [71]. Fads1 is involved in the biosynthesis of unsaturated fatty acids and the regulation of cell membrane fluidity [72], while Adcy1 and Adcy8 participate in cAMP signaling pathways that influence lipid metabolism by modulating fatty acid synthesis in response to AMP/ATP ratios [73]. Additionally, Ncoa2 mediates the co-activation of genes involved in lipid metabolism (Rollins et al., 2015). These metabolic processes occur in the context of key circadian rhythms genes such as Clock, Bmal1, Dbp, Per1, Npas2, and Nr1d2, highlighting the critical role of circadian rhythms in regulating lipid metabolism. Specifically, Clock and Bmal1 form a heterodimer that enhances the expression of Ppargc1a, promoting fatty acid oxidation and mitochondrial biogenesis in response to increased energy demands during activities like fasting or physical exercise, which mainly correspond to active phase of the body during the day [74].

Our findings show that other circadian genes, such as Dbp, Per1, Npas2 and Nr1d2, have more specific roles. Dbp increases its levels at the start of the active phase to activate Ppargc1a, responding to energy demand spikes [75]. Per1 down-regulates the Clock-Bmal1 complex at specific times during the active phase, when its activity is less needed [76]. Npas2 interacts with Ppargc1a in a positive feedback loop, enhancing lipid metabolism to meet energy demands [77]. In contrast, Nr1d2 represses Ppargc1a when energy demand decreases [78]. Fads1 is regulated similarly to Ppargc1a by circadian genes, specifically for fatty acid desaturation. Adcy1 and Adcy8 regulate cAMP levels during the active phase, which promotes lipolysis and fatty acid oxidation. Finally, Ncoa2 activates genes that modulate the Clock-Bmal1 complex, including the periodic genes (Per1, Per2 and Per3), cryptochrome genes (Cry1 and Cry2), Dbp gene, Rev-erb genes (Nr1d1 and Nr1d2), ROR genes (Rora, Rorb and Rorg) and metabolic genes (Ppara, Nampt and Gys2).

4.1. New pathways related to metabolism

The Boolean network suggests additional gene interactions, such as the pathway Tef --> Fbxw11 --> Dbp --> Pgr --> Ppargc1a, which is not previously reported in the literature. This pathway implies that Ppargc1a is influenced not only by circadian genes, but also by genes like Tef, Fbxw11 and Pgr. Tef, which regulates transcription via the TATA-box element, may modulate Fbxw11, a gene responsible for targeting proteins for degradation [79]. This interaction could influence Dbp, potentially modulating its expression. Studies suggest that Dbp could affect Pgr expression, acting as a signal transducer [80]. Moreover, Pgr is susceptible to daily regulation, particularly through Dbp, and is involved in interventions like hormonal therapies [81] and physiological regulation [82]. Finally, Pgr could modulate Ppargc1a expression, as similar hormonal effects, such as insulin or Hif1a in hypoxia, have been documented [83,84].

Another potential undocumented pathway is Ppargc1a --> Ep300 --> Ncoa2. While the direct influence of Ppargc1a on Ep300 has not been previously reported, the relationship from Ep300 to Ppargc1a is well-documented, where Ep300 acts as a co-activator, particularly in obesity and thermogenesis [83]. Notably, studies have shown that Ppargc1a can function as a co-activator [85], suggesting that, in this context, Ppargc1a may promote Ep300 activity. Regarding Ep300’s activation of Ncoa2, this is supported by Ep300’s histone acetyltransferase (HAT) activity, which modifies chromatin structure, making it more accessible and facilitating the transcription of target genes through nuclear receptors. This mechanism is particularly relevant for the p160 co-activator family, to which Ncoa2 belongs [86].

4.2. Obesity effects

Our Boolean model also revealed that obesity leads to down-regulation of key circadian genes, Bmal1 and Clock, which may impact several metabolic processes, including glucose homeostasis and insulin response [87,88]. Interestingly, Bmal1 influences Fads1, which in turn affects Clock, and together, Bmal1 and Clock regulate lipid metabolism through E-transcriptional activation [87]. This suggests bidirectional interactions between lipid metabolism and circadian rhythms under normal conditions. In obesity, the downregulation of both Bmal1 and Fads1 leads to impaired coordination between Bmal1 and Clock, further compromising lipid metabolism regulation [89]. Additionally, this disruption may worsen over time, as evidenced by recent findings linking circadian dysfunction in omental fat with obesity [90] and the presence of single nucleotide polymorphisms in the Clock gene has been associated with morbid obesity [91]. This circular pathway appears to be previously undocumented.

4.3. Limitations of this study

The main limitation of this study is the use of the Boolean model, which simplifies by reducing it to two states, failing to capture the full complexity of gene interactions. As previously mentioned, this approach offers a tractable framework for modeling gene-level interactions, its binary “on/off” cannot capture the graded or temporal nuances of gene regulation. Despite this limitation, the model used provides valuable insights that could be expanded upon with more detailed models, such as probabilistic or differential-equation models.

Our analysis was also constrained by the limited gene set – primarily lipid metabolism- derived from a single cortical transcriptome dataset. This small size and cortex-only focus may limit the generalizability of our findings. Cross-validating our results using larger, independent obesity-related datasets (e.g., hypothalamus, liver, adipose tissue etc) will expand the network to include additional genes impacted by these analyses.

Finally, the GENIE3 algorithm infers directed edges from expression data alone and may miss well-documented interactions (e.g., the Clock-Bmal1 feedback loop) when statistical support is weak. Future studies should integrate curated interaction databases and literature-derived edges to reinforce and refine network topology.

5. Conclusions

Our study on circadian rhythms and obesity has revealed significant interactions, suggesting that disruptions in these rhythms worsen metabolic dysfunctions. This finding highlights the importance of maintaining regular circadian rhythms to mitigate the health risks associated with obesity.

The analysis of DEGs linked to circadian rhythms provided valuable insight into the functional mechanism underlying obesity. Enrichment analysis identified key DEGs that help explain how obesity alters circadian functions, contributing to conditions like metabolic syndrome and its comorbidities. Our Boolean model effectively captured this complex interaction; however, given the complexity of these interactions, further studies are needed to better understand the causal relationships between circadian rhythms disturbances and obesity.

Supporting information

S1 Fig. Preparation of the transcriptomes: (A) normalization and (B) representation based on the mean-standard deviation model.

https://doi.org/10.1371/journal.pone.0331218.s001

(DOCX)

S2 Fig. Iterations of the genes Dbp, Fbxw11, Nrg1 and Pgr to produce the two states of attractor 40.

https://doi.org/10.1371/journal.pone.0331218.s002

(DOCX)

References

  1. 1. Koliaki C, Dalamaga M, Liatis S. Update on the Obesity Epidemic: After the Sudden Rise, Is the Upward Trajectory Beginning to Flatten?. Curr Obes Rep. 2023;12(4):514–27. pmid:37779155
  2. 2. Popko K, Gorska E, Stelmaszczyk-Emmel A, Plywaczewski R, Stoklosa A, Gorecka D, et al. Proinflammatory cytokines Il-6 and TNF-α and the development of inflammation in obese subjects. Eur J Med Res. 2010;15 Suppl 2(Suppl 2):120–2. pmid:21147638
  3. 3. Martin KA, Mani MV, Mani A. New targets to treat obesity and the metabolic syndrome. Eur J Pharmacol. 2015;763(Pt A):64–74. pmid:26001373
  4. 4. Hidalgo-Lanussa O, Baez-Jurado E, Echeverria V, Ashraf GM, Sahebkar A, Garcia-Segura LM, et al. Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds. J Neuroendocrinol. 2020;32(1):e12776. pmid:31334878
  5. 5. Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population. Int J Med Sci. 2016;13(1):25–38. pmid:26816492
  6. 6. Ruck L, Wiegand S, Kühnen P. Relevance and consequence of chronic inflammation for obesity development. Mol Cell Pediatr. 2023;10(1):16. pmid:37957462
  7. 7. Salas-Venegas V, Flores-Torres RP, Rodríguez-Cortés YM, Rodríguez-Retana D, Ramírez-Carreto RJ, Concepción-Carrillo LE, et al. The Obese Brain: Mechanisms of Systemic and Local Inflammation, and Interventions to Reverse the Cognitive Deficit. Front Integr Neurosci. 2022;16:798995. pmid:35422689
  8. 8. Vesga-Jiménez DJ, Martin C, Barreto GE, Aristizábal-Pachón AF, Pinzón A, González J. Fatty Acids: An Insight into the Pathogenesis of Neurodegenerative Diseases and Therapeutic Potential. Int J Mol Sci. 2022;23(5):2577. pmid:35269720
  9. 9. Martin-Jiménez CA, García-Vega Á, Cabezas R, Aliev G, Echeverria V, González J, et al. Astrocytes and endoplasmic reticulum stress: A bridge between obesity and neurodegenerative diseases. Prog Neurobiol. 2017;158:45–68. pmid:28802884
  10. 10. Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8(1):267. pmid:37433768
  11. 11. Chen J, Pan S, Tan Y, Wu Y, Huang T, Huang B, et al. Genetic Associations between Obesity and Brain Cortical Thickness: Combined Genetic Correlation, Multi-Trait Meta-Analysis, and Mendelian Randomization. Neuroendocrinology. 2025;115(3–4):308–14. pmid:39832494
  12. 12. Westwater ML, Vilar-López R, Ziauddeen H, Verdejo-García A, Fletcher PC. Combined effects of age and BMI are related to altered cortical thickness in adolescence and adulthood. Dev Cogn Neurosci. 2019;40:100728. pmid:31751856
  13. 13. Rosch KS, Thapaliya G, Plotkin M, Mostofsky SH, Carnell S. Shared and distinct alterations in brain morphology in children with ADHD and obesity: Reduced cortical surface area in ADHD and thickness in overweight/obesity. J Psychiatr Res. 2024;180:103–12. pmid:39388790
  14. 14. Schwarz NF, Nordstrom LK, Pagen LHG, Palombo DJ, Salat DH, Milberg WP, et al. Differential associations of metabolic risk factors on cortical thickness in metabolic syndrome. Neuroimage Clin. 2017;17:98–108. pmid:29062686
  15. 15. Shaw ME, Sachdev PS, Abhayaratna W, Anstey KJ, Cherbuin N. Body mass index is associated with cortical thinning with different patterns in mid- and late-life. Int J Obes (Lond). 2018;42(3):455–61. pmid:28993708
  16. 16. McKlveen JM, Myers B, Flak JN, Bundzikova J, Solomon MB, Seroogy KB, et al. Role of prefrontal cortex glucocorticoid receptors in stress and emotion. Biol Psychiatry. 2013;74(9):672–9. pmid:23683655
  17. 17. Noh J. The Effect of Circadian and Sleep Disruptions on Obesity Risk. J Obes Metab Syndr. 2018;27(2):78–83. pmid:31089546
  18. 18. Garaulet M, Madrid JA. Chronobiological aspects of nutrition, metabolic syndrome and obesity. Adv Drug Deliv Rev. 2010;62(9–10):967–78. pmid:20580916
  19. 19. Shi S, Ansari TS, McGuinness OP, Wasserman DH, Johnson CH. Circadian disruption leads to insulin resistance and obesity. Curr Biol. 2013;23(5):372–81. pmid:23434278
  20. 20. Davis R, Rogers M, Coates AM, Leung GKW, Bonham MP. The Impact of Meal Timing on Risk of Weight Gain and Development of Obesity: a Review of the Current Evidence and Opportunities for Dietary Intervention. Curr Diab Rep. 2022;22(4):147–55. pmid:35403984
  21. 21. Summa KC, Turek FW. Chronobiology and obesity: Interactions between circadian rhythms and energy regulation. Adv Nutr. 2014;5(3):312S-9S. pmid:24829483
  22. 22. Pacheco-Bernal I, Becerril-Pérez F, Aguilar-Arnal L. Circadian rhythms in the three-dimensional genome: implications of chromatin interactions for cyclic transcription. Clin Epigenetics. 2019;11(1):79. pmid:31092281
  23. 23. Froy O. Metabolism and circadian rhythms--implications for obesity. Endocr Rev. 2010;31(1):1–24. pmid:19854863
  24. 24. Chaput J-P, McHill AW, Cox RC, Broussard JL, Dutil C, da Costa BGG, et al. The role of insufficient sleep and circadian misalignment in obesity. Nat Rev Endocrinol. 2023;19(2):82–97. pmid:36280789
  25. 25. Dobrić V, Milošević P, Rakićević A, Petrović B, Poledica A. Interpolative boolean networks. Complexity. 2017;2017:2647164.
  26. 26. Lowe CJ, Reichelt AC, Hall PA. The Prefrontal Cortex and Obesity: A Health Neuroscience Perspective. Trends Cogn Sci. 2019;23(4):349–61. pmid:30824229
  27. 27. Zhou H, Hu Y, Li G, Zhang W, Ji W, Feng Y, et al. Obesity is associated with progressive brain structural changes. Obesity (Silver Spring). 2025;33(4):709–19. pmid:40025869
  28. 28. Silva DGM, de Santana JH, Bernardo EM, de Sousa Fernandes MS, Yagin FH, Al-Hashem F, et al. The REDOX balance in the prefrontal cortex is positively modulated by aerobic exercise and altered by overfeeding. Sci Rep. 2025;15(1):13787. pmid:40259099
  29. 29. Liang C, Lu H, Wang X, Su J, Qi F, Shang Y, et al. Neuron stress-related genes serve as new biomarkers in hypothalamic tissue following high fat diet. Front Endocrinol (Lausanne). 2024;15:1443880. pmid:39717104
  30. 30. Hidalgo-Lanussa O, González Santos J, Barreto GE. Sex-specific vulnerabilities in human astrocytes underpin the differential impact of palmitic acid. Neurobiol Dis. 2024;195:106489. pmid:38552721
  31. 31. Rojas-Cruz AF, Martín-Jiménez CA, González J, González-Giraldo Y, Pinzón AM, Barreto GE, et al. Palmitic Acid Upregulates Type I Interferon-Mediated Antiviral Response and Cholesterol Biosynthesis in Human Astrocytes. Mol Neurobiol. 2023;60(8):4842–54. pmid:37184765
  32. 32. Castellanos DB, Martín-Jiménez CA, Pinzón A, Barreto GE, Padilla-González GF, Aristizábal A, et al. Metabolomic Analysis of Human Astrocytes in Lipotoxic Condition: Potential Biomarker Identification by Machine Learning Modeling. Biomolecules. 2022;12(7):986. pmid:35883542
  33. 33. Vesga-Jiménez DJ, Martín-Jiménez CA, Grismaldo Rodríguez A, Aristizábal-Pachón AF, Pinzón A, Barreto GE, et al. Tibolone Pre-Treatment Ameliorates the Dysregulation of Protein Translation and Transport Generated by Palmitic Acid-Induced Lipotoxicity in Human Astrocytes: A Label-Free MS-Based Proteomics and Network Analysis. Int J Mol Sci. 2022;23(12):6454. pmid:35742897
  34. 34. Yanguas-Casás N, Torres C, Crespo-Castrillo A, Diaz-Pacheco S, Healy K, Stanton C, et al. High-fat diet alters stress behavior, inflammatory parameters and gut microbiota in Tg APP mice in a sex-specific manner. Neurobiol Dis. 2021;159:105495. pmid:34478848
  35. 35. Silva SC de A, de Lemos MDT, Dos Santos Junior OH, Rodrigues TO, Silva TL, da Silva AI, et al. Overweight during development dysregulates cellular metabolism and critical genes that control food intake in the prefrontal cortex. Physiol Behav. 2024;276:114453. pmid:38159589
  36. 36. Yoon G, Cho KA, Song J, Kim Y-K. Transcriptomic Analysis of High Fat Diet Fed Mouse Brain Cortex. Front Genet. 2019;10:83. pmid:30838024
  37. 37. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. pmid:25516281
  38. 38. Team RC. R: A language and environment for statistical computing. 2024. [cited 30 September 2024]. https://www.R-project.org/
  39. 39. Evans C, Hardin J, Stoebel DM. Selecting between-sample RNA-Seq normalization methods from the perspective of their assumptions. Brief Bioinform. 2018;19(5):776–92. pmid:28334202
  40. 40. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. pmid:25605792
  41. 41. Huber N. ggdendro: Create dendrograms and tree diagrams using ‘ggplot2’. 2022.
  42. 42. Blighe K, Rana S, Lewis M. Enhanced volcano: publication-ready volcano plots with enhanced colouring and labeling. 2024.
  43. 43. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. pmid:19131956
  44. 44. Zhang S-B, Lai J-H. Exploring information from the topology beneath the Gene Ontology terms to improve semantic similarity measures. Gene. 2016;586(1):148–57. pmid:27080954
  45. 45. Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. pmid:30944313
  46. 46. Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638–46. pmid:36370105
  47. 47. Oughtred R, Stark C, Breitkreutz B-J, Rust J, Boucher L, Chang C, et al. The BioGRID interaction database: 2019 update. Nucleic Acids Res. 2019;47(D1):D529–41. pmid:30476227
  48. 48. Türei D, Valdeolivas A, Gul L, Palacio-Escat N, Klein M, Ivanova O, et al. Integrated intra- and intercellular signaling knowledge for multicellular omics analysis. Mol Syst Biol. 2021;17(3):e9923. pmid:33749993
  49. 49. Huynh-Thu VA, Irrthum A, Wehenkel L, Geurts P. Inferring regulatory networks from expression data using tree-based methods. PLoS One. 2010;5(9):e12776. pmid:20927193
  50. 50. Schwab JD, Kühlwein SD, Ikonomi N, Kühl M, Kestler HA. Concepts in Boolean network modeling: What do they all mean?. Comput Struct Biotechnol J. 2020;18:571–82. pmid:32257043
  51. 51. Fumiã HF, Martins ML. Boolean network model for cancer pathways: predicting carcinogenesis and targeted therapy outcomes. PLoS One. 2013;8(7):e69008. pmid:23922675
  52. 52. Tercan B, Aguilar B, Huang S, Dougherty ER, Shmulevich I. Probabilistic boolean networks predict transcription factor targets to induce transdifferentiation. iScience. 2022;25(9):104951. pmid:36093045
  53. 53. Breiman L. Random Forests. Mach Learn. 2001;45:5–32.
  54. 54. Klauschen F, Dippel J, Keyl P, Jurmeister P, Bockmayr M, Mock A, et al. Toward Explainable Artificial Intelligence for Precision Pathology. Annu Rev Pathol. 2024;19:541–70. pmid:37871132
  55. 55. Melenhorst JJ, Chen GM, Wang M, Porter DL, Chen C, Collins MA, et al. Decade-long leukaemia remissions with persistence of CD4+ CAR T cells. Nature. 2022;602(7897):503–9. pmid:35110735
  56. 56. Kang Y, Thieffry D, Cantini L. Evaluating the Reproducibility of Single-Cell Gene Regulatory Network Inference Algorithms. Front Genet. 2021;12:617282. pmid:33828580
  57. 57. Müssel C, Hopfensitz M, Kestler HA. BoolNet--an R package for generation, reconstruction and analysis of Boolean networks. Bioinformatics. 2010;26(10):1378–80. pmid:20378558
  58. 58. Ruiz-Silva A, Gilardi-Velázquez HE, Campos E. Emergence of synchronous behavior in a network with chaotic multistable systems. Chaos, Solitons & Fractals. 2021;151:111263.
  59. 59. Fagiani F, Di Marino D, Romagnoli A, Travelli C, Voltan D, Di Cesare Mannelli L, et al. Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduct Target Ther. 2022;7(1):41. pmid:35136018
  60. 60. Rutter J, Reick M, Wu LC, McKnight SL. Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science. 2001;293(5529):510–4. pmid:11441146
  61. 61. Halling JF, Pilegaard H. PGC-1α-mediated regulation of mitochondrial function and physiological implications. Appl Physiol Nutr Metab. 2020;45(9):927–36. pmid:32516539
  62. 62. Calder PC. Long-chain fatty acids and inflammation. Proc Nutr Soc. 2012;71(2):284–9. pmid:22369781
  63. 63. Ciesielska A, Kwiatkowska K. Modification of pro-inflammatory signaling by dietary components: The plasma membrane as a target. Bioessays. 2015;37(7):789–801. pmid:25966354
  64. 64. Devasani K, Yao Y. Expression and functions of adenylyl cyclases in the CNS. Fluids Barriers CNS. 2022;19(1):23. pmid:35307032
  65. 65. Qu L, Yin Y, Yin T, Zhang X, Zhou X, Sun L. NCOA2-induced secretion of leptin leads to fetal growth restriction via the NF-κB signaling pathway. Ann Transl Med. 2023;11(4):166. pmid:36923094
  66. 66. Talukdar PD, Chatterji U. Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases. Signal Transduct Target Ther. 2023;8(1):427. pmid:37953273
  67. 67. Haddadi N, Lin Y, Travis G, Simpson AM, Nassif NT, McGowan EM. PTEN/PTENP1: “Regulating the regulator of RTK-dependent PI3K/Akt signalling”, new targets for cancer therapy. Mol Cancer. 2018;17(1):37. pmid:29455665
  68. 68. Csardi G, Nepusz T (2006) The Igraph Software Package for Complex Network Research. InterJournal, Complex Systems 1695:1–9.
  69. 69. Mori T, Akutsu T. Attractor detection and enumeration algorithms for Boolean networks. Comput Struct Biotechnol J. 2022;20:2512–20. pmid:35685366
  70. 70. Agarwal RP, Bohner M, Crace SR, O’Regan D. Discrete Oscillation Theory. New York: Hindawi Publishing Corporation. 2005.
  71. 71. Cheng C-F, Ku H-C, Lin H. PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation. Int J Mol Sci. 2018;19(11):3447. pmid:30400212
  72. 72. Reynolds LM, Dutta R, Seeds MC, Lake KN, Hallmark B, Mathias RA, et al. FADS genetic and metabolomic analyses identify the ∆5 desaturase (FADS1) step as a critical control point in the formation of biologically important lipids. Sci Rep. 2020;10(1):15873. pmid:32985521
  73. 73. Zhang M, Wang H. Ca2+-stimulated ADCY1 and ADCY8 regulate distinct aspects of synaptic and cognitive flexibility. Front Cell Neurosci. 2023;17:1215255. pmid:37465213
  74. 74. Feng D, Lazar MA. Clocks, metabolism, and the epigenome. Mol Cell. 2012;47(2):158–67. pmid:22841001
  75. 75. Yamaguchi S, Mitsui S, Yan L, Yagita K, Miyake S, Okamura H. Role of DBP in the circadian oscillatory mechanism. Mol Cell Biol. 2000;20(13):4773–81. pmid:10848603
  76. 76. Takahashi JS. Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet. 2017;18(3):164–79. pmid:27990019
  77. 77. O’Neil D, Mendez-Figueroa H, Mistretta T-A, Su C, Lane RH, Aagaard KM. Dysregulation of Npas2 leads to altered metabolic pathways in a murine knockout model. Mol Genet Metab. 2013;110(3):378–87. pmid:24067359
  78. 78. Yu M, Li W, Wang Q, Wang Y, Lu F. Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility. Oncogene. 2018;37(35):4838–53. pmid:29773903
  79. 79. Holt RJ, Young RM, Crespo B, Ceroni F, Curry CJ, Bellacchio E, et al. De Novo Missense Variants in FBXW11 Cause Diverse Developmental Phenotypes Including Brain, Eye, and Digit Anomalies. Am J Hum Genet. 2019;105(3):640–57. pmid:31402090
  80. 80. Castelló MJ, Carrasco JL, Vera P. DNA-binding protein phosphatase AtDBP1 mediates susceptibility to two potyviruses in Arabidopsis. Plant Physiol. 2010;153(4):1521–5. pmid:20508138
  81. 81. Rahman SA, Grant LK, Gooley JJ, Rajaratnam SMW, Czeisler CA, Lockley SW. Endogenous Circadian Regulation of Female Reproductive Hormones. J Clin Endocrinol Metab. 2019;104(12):6049–59. pmid:31415086
  82. 82. Shao S, Zhao H, Lu Z, Lei X, Zhang Y. Circadian Rhythms Within the Female HPG Axis: From Physiology to Etiology. Endocrinology. 2021;162(8):bqab117. pmid:34125877
  83. 83. Qian L, Zhu Y, Deng C, Liang Z, Chen J, Chen Y, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases. Signal Transduct Target Ther. 2024;9(1):50. pmid:38424050
  84. 84. Soyal SM, Bonova P, Kwik M, Zara G, Auer S, Scharler C, et al. The Expression of CNS-Specific PPARGC1A Transcripts Is Regulated by Hypoxia and a Variable GT Repeat Polymorphism. Mol Neurobiol. 2020;57(2):752–64. pmid:31471878
  85. 85. Finck BN, Kelly DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest. 2006;116(3):615–22. pmid:16511594
  86. 86. Rollins DA, Coppo M, Rogatsky I. Minireview: nuclear receptor coregulators of the p160 family: insights into inflammation and metabolism. Mol Endocrinol. 2015;29(4):502–17. pmid:25647480
  87. 87. Rudic RD, McNamara P, Curtis A-M, Boston RC, Panda S, Hogenesch JB, et al. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol. 2004;2(11):e377. pmid:15523558
  88. 88. Wondmkun YT. Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications. Diabetes Metab Syndr Obes. 2020;13:3611–6. pmid:33116712
  89. 89. Gooley JJ. Circadian regulation of lipid metabolism. Proc Nutr Soc. 2016;75(4):440–50. pmid:27225642
  90. 90. Maury E, Navez B, Brichard SM. Circadian clock dysfunction in human omental fat links obesity to metabolic inflammation. Nat Commun. 2021;12(1):2388. pmid:33888702
  91. 91. Torrego-Ellacuría M, Barabash A, Matía-Martín P, Sánchez-Pernaute A, Torres AJ, Calle-Pascual AL, et al. Influence of CLOCK Gene Variants on Weight Response after Bariatric Surgery. Nutrients. 2022;14(17):3472. pmid:36079729